Entertainer Faraaz Khan has died, affirmed Pooja Bhatt on Wednesday. Faraaz was being treated at an emergency clinic in Bengaluru for a neurological issue. He was conceded in the ICU. 

Pooja took to Twitter to share the updates on Faraaz’s end. She tweeted, “With crushing sadness, I break the news that #FaraazKhan has left us for what I accept, is a superior spot. Appreciation to just for your assistance and great wishes when he required it most. Kindly keep his family in your musings and supplications. The void he has given up will be difficult to fill.” 

Faraz Khan had acted in films like Mehndi (1998), Fareb (1996), Dulhan Banoo Main Teri (1999) and Chand Bujh Gaya (2005) among others. 

Half a month prior, his sibling Fahmaan Khan had shared insights regarding the entertainer’s wellbeing and had mentioned monetary assistance for the treatment. After Fahmaan’s allure, Salman Khan had approached to help with Faraaz’s clinical costs. 

His relatives, Farhad Abousher and Ahmed Shamoon, had begun a raising support mission to accumulate assets for his treatment. 

They had said that Khan had been experiencing a hack and a disease in his chest for almost a year and it exasperated as of late. 

Khan endured seizures threefold when he was being taken to the medical clinic and it was later analyzed that he had a “herpes contamination in his cerebrum that had spread from his chest”. 

Bhatt had a month ago encouraged individuals to bringing to the table money related help for Khan’s treatment. Following which, genius Salman Khan had paid for Khan’s clinical costs. 

Khan had denoted his introduction in Bollywood in 1996 with Vikram Bhatt-coordinated ‘Fareb’. He discovered acclaim after he included as Rani Mukherjee’s significant other in social show ‘Mehendi’. 

His film credits likewise incorporate motion pictures, for example, ‘Prithvi’, ‘Dulhan Banoo Main Teri’, ‘Dil Ne Phir Yaad Kiya’ and ‘Chand Bujh Gaya’. 

Tap To Explore More : Times Of India

Also Read : 53.51% TURNOUT IN PHASE 2 ASSEMBLY POLLS IN BIHAR, A FIGURE LIKELY TO GO UP: EC